Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-05-14

Clinical Trial Update: A Study of NeoRecormon in Patients With Chronic Kidney Disease. [Phase 4]

View source ↗

Summary

Phase 4 study of NeoRecormon in patients with chronic kidney disease evaluating anemia management has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NeoRecormon (epoetin beta)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 4 | Status: COMPLETED